Cancer BiologybioRxivPreprint
Deep learning-driven morphology analysis enables label-free classification of therapeutic agent- naive versus resistant cancer cells
Cyril Y. Ramathal, Kiran Saini, Zhouyang Lian…·Andreja Jovic
This study uses deep learning to classify drug-naive and resistant cancer cells based on morphology, achieving high accuracy across multiple cancer types and drug classes.